Begin typing your search above and press return to search.
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
access_time 16 Aug 2023 5:46 AM GMT
May that spark not be extinguished
access_time 2 Dec 2023 8:55 AM GMT
A Constitution always in the making
access_time 27 Nov 2023 11:43 AM GMT
Debunking myth of Israel’s existence
access_time 23 Oct 2023 7:01 AM GMT
Homechevron_rightLifestylechevron_rightHealthchevron_rightUSFDA authorizes first...

USFDA authorizes first at-home Covid-19 test kit

USFDA authorizes first at-home Covid-19 test kit

Hong Kong/ New York: The U.S. approved the first COVID-19 All-In-One Test Kit for home use that provides results within 30 minutes. This is anticipated to contribute considerably in battling the pandemic as testing capabilities come under heavy strain nationwide.

The single-use test, made by Lucira Health, has been given emergency use authorization for home use with self-collected nasal swab samples in individuals of age 14 and above who are suspected of COVID-19 by their health care provider, the US Food and Drug Administration said on Tuesday. With a prescription, people can acquire it for around $50, as it said to be accessible across the country by spring 2021.

While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home. The clearance comes at a time of rising Coronavirus cases across the country, with 11.4 million cases recorded until Tuesday and more than 2,49,000 deaths.

"This new testing option is an important diagnostic advancement to address the pandemic and reduce the public burden of disease transmission." The FDA Commissioner Stephen Hahn said in a statement.

The product, authorized for use in hospitals and point-of-care settings, unlike antigen tests are highly reliable and according to Lucira Health, the tests have a sensitivity of about 94.1 per cent and a specificity of 98 per cent.

Show Full Article
TAGS:COVID19Home Covid Test Kit
Next Story